Skip to content

Clinical trials

Completed Pituitary ACTH Hypersecretion trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pituitary ACTH Hypersecretion Status: Completed Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20091
20101
20114
20135
20142
20151
20163
20171
20182
20192
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Corcept Therapeutics5
Cortendo AB2
RECORDATI GROUP2
Assistance Publique - Hôpitaux de Paris1
Cedars-Sinai Medical Center1
Crinetics Pharmaceuticals Inc.1
Endocrinology Research Centre, Moscow1
Hospices Civils de Lyon1
Institut National de la Santé Et de la Recherche Médicale, France1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pituitary ACTH Hypersecretion29
Cushing Syndrome8
ACTH Syndrome, Ectopic7
Pituitary Diseases5
Acromegaly3
Adrenal Cortex Neoplasms3
Pituitary Neoplasms3
Adrenocortical Hyperfunction2
Choristoma2
Diabetes Mellitus, Type 22

Trials

Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.